Neuronal Voltage-Gated Potassium Channel Complex Autoimmunity in Children

Gutman, 2005, International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels, Pharmacol Rev, 57, 473, 10.1124/pr.57.4.10 Yellen, 2002, The voltage-gated potassium channels and their relatives, Nature, 419, 35, 10.1038/nature00978 Hart, 1997, Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia, Ann Neurol, 41, 238, 10.1002/ana.410410215 Sinha, 1991, Autoimmune aetiology for acquired neuromyotonia (Isaacs’ syndrome), Lancet, 338, 75, 10.1016/0140-6736(91)90073-X Vernino, 2002, Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability, Muscle Nerve, 26, 702, 10.1002/mus.10266 Liguori, 2001, Morvan’s syndrome: Peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels, Brain, 124, 2417, 10.1093/brain/124.12.2417 Vernino, 2002, Autoimmune autonomic neuropathy and neuromuscular hyperexcitability disorders, 1013 Majoie, 2006, Antibodies to voltage-gated potassium and calcium channels in epilepsy, Epilepsy Res, 71, 135, 10.1016/j.eplepsyres.2006.06.003 McKnight, 2005, Serum antibodies in epilepsy and seizure-associated disorders, Neurology, 65, 1730, 10.1212/01.wnl.0000187129.66353.13 Thieben, 2004, Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody, Neurology, 62, 1177, 10.1212/01.WNL.0000122648.19196.02 Vincent, 2004, Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis, Brain, 127, 701, 10.1093/brain/awh077 Pozo-Rosich, 2003, Voltage-gated potassium channel antibodies in limbic encephalitis, Ann Neurol, 54, 530, 10.1002/ana.10713 Lai, 2010, Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series, Lancet Neurol, 9, 776, 10.1016/S1474-4422(10)70137-X Irani, 2010, Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia, Brain, 133, 2734, 10.1093/brain/awq213 Tan, 2008, Clinical spectrum of voltage-gated potassium channel autoimmunity, Neurology, 70, 1883, 10.1212/01.wnl.0000312275.04260.a0 Knowles, 2002, A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility, Scand J Gastroenterol, 37, 166, 10.1080/003655202753416821 Dhamija, 2008, Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility, Clin Gastroenterol Hepatol, 6, 988, 10.1016/j.cgh.2008.04.009 Viallard, 2005, Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction, Eur Neurol, 53, 60, 10.1159/000084300 Cikes, 1988, Striational autoantibodies: Quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of d-penicillamine or allogeneic bone marrow, Mayo Clin Proc, 63, 474, 10.1016/S0025-6196(12)65645-6 Lennon, 1994, The case for a descriptive generic nomenclature: Clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies, Neurology, 44, 2412, 10.1212/WNL.44.12.2412 Joshi, 2003, Chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity, Pediatr Hematol Oncol, 25, 900, 10.1097/00043426-200311000-00015 Dalmau, 2008, Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies, Lancet Neurol, 7, 1091, 10.1016/S1474-4422(08)70224-2 Apiwattanakul, 2010, Eliminating false-positive results in serum tests for neuromuscular autoimmunity, Muscle Nerve, 41, 702, 10.1002/mus.21653 Aston PA, Lennon VA, McKeon A, Lachance D, Klein C, Pittock SJ. Neuronal voltage-gated potassium channel (VGKC) autoantibodies in routine paraneoplastic evaluation: Frequency and clinical correlates [abstract]. Ann Neurol 2010;68(Suppl. 14):S32. Antunes, 2000, Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus, J Pediatr Hematol Oncol, 22, 315, 10.1097/00043426-200007000-00007 McKeon, 2010, Immunotherapy-responsive dementias and encephalopathies, Continuum Lifelong Learning Neurol, 16, 80, 10.1212/01.CON.0000368213.63964.34